Abolis
Developer of a microbial biotechnology platform designed to change production models of high-value molecules. The company offers advanced genetic tools, ML-driven pathway optimization, and scalable bi...
Valuation
$53.1M
Market implied
Share Price
N/A
Total Raised
$40.1M
Last Round
N/A